[The physiology of incretins]. / Az inkretinek elettana.
Orv Hetil
; 152(48): 1922-30, 2011 Nov 27.
Article
em Hu
| MEDLINE
| ID: mdl-22167829
ABSTRACT
The discovery of incretins-glucagon-like peptide (GLP)-1 and glucose-dependent insulinotrop peptide (GIP)-, clarification of their physiological properties as well as therapeutic application of incretin-based blood glucose lowering drugs opened new perspectives in the medical management of type 2 diabetes. New results of basic research investigations led to revaluation of the role of GIP in metabolic processes and a more established use of GLP-1 action. The article overviews the most relevant data of production and effects of incretins, as well as future possibilities of their therapeutic use.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Polipeptídeo Inibidor Gástrico
/
Diabetes Mellitus
/
Peptídeos Semelhantes ao Glucagon
/
Incretinas
Limite:
Animals
/
Humans
Idioma:
Hu
Revista:
Orv Hetil
Ano de publicação:
2011
Tipo de documento:
Article